Suppr超能文献

谁会使用 PrEP?伦敦男男性行为者中与使用意向相关的因素:一项社区调查。

Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey.

机构信息

HIV and STI Department, Health Protection Agency-Colindale, London NW9 5EQ, UK;

出版信息

Sex Transm Infect. 2013 May;89(3):207-11. doi: 10.1136/sextrans-2012-050648. Epub 2012 Sep 26.

Abstract

OBJECTIVE

To assess current and intended future use of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) and characterise those attending sexual health clinics, the anticipated PrEP delivery setting.

DESIGN

Cross-sectional study.

METHODS

Self-administered survey of 842 HIV negative MSM recruited from social venues in London in 2011.

RESULTS

One in 10 (10.2%, 83/814, 95% CI 8.2% to 12.5%) and one in 50 (2.1%, 17/809, 95% CI 1.2% to 3.3%) reported having ever used post-exposure prophylaxis (PEP) and PrEP respectively. Half reported they would be likely to use PrEP if it became available as a daily pill (50.3%, 386/786, 95% CI 46.7% to 53.9%). MSM were more likely to consider future PrEP use if they were <35 years (adjusted OR (AOR) 1.57, 95% CI 1.16 to 2.14), had unprotected anal intercourse with casual partners (AOR 1.70, 95% CI 1.13 to 2.56), and had previously used PEP (AOR 1.94, 95% CI 1.17 to 3.24). Over half of MSM (54.8% 457/834 95% CI 51.3 to 58.2) attended a sexual health clinic the previous year. Independent factors associated with attendance were age <35 (AOR 2.29, 95% CI 1.68 to 3.13), and ≥ 10 anal sex partners in the last year (AOR 2.49, 95% CI 1.77 to 3.52).

CONCLUSIONS

The concept of PrEP for HIV prevention in the form of a daily pill is acceptable to half of sexually active MSM in London. MSM reporting higher risk behaviours attend sexual health clinics suggesting this is a suitable setting for PrEP delivery.

摘要

目的

评估男男性行为者(MSM)中目前和未来使用暴露前预防(PrEP)的情况,并描述那些在性健康诊所就诊的人群,这是预期的 PrEP 提供场所。

设计

2011 年在伦敦的社交场所招募了 842 名 HIV 阴性的 MSM 进行横断面研究。

方法

对 814 名参与者进行了自我管理的调查,他们在 2011 年从伦敦的社交场所招募。

结果

十分之一(10.2%,83/814,95%可信区间 8.2%至 12.5%)和二十分之一(2.1%,17/809,95%可信区间 1.2%至 3.3%)的人报告曾经使用过接触后预防(PEP)和 PrEP。如果 PrEP 成为一种每日药丸,一半的人表示他们可能会使用(50.3%,386/786,95%可信区间 46.7%至 53.9%)。如果 MSM 年龄小于 35 岁(调整后的比值比(AOR)1.57,95%可信区间 1.16 至 2.14)、与偶然伴侣发生无保护肛交(AOR 1.70,95%可信区间 1.13 至 2.56)或曾经使用过 PEP(AOR 1.94,95%可信区间 1.17 至 3.24),他们更有可能考虑未来使用 PrEP。超过一半的 MSM(54.8%,457/834,95%可信区间 51.3%至 58.2%)在去年的某个时候去过性健康诊所。与就诊相关的独立因素包括年龄小于 35 岁(AOR 2.29,95%可信区间 1.68 至 3.13)和过去一年有 10 个以上的肛交伴侣(AOR 2.49,95%可信区间 1.77 至 3.52)。

结论

在伦敦,有一半活跃的 MSM 接受了将 PrEP 作为每日药丸用于 HIV 预防的概念。报告风险行为较高的 MSM 会去性健康诊所就诊,这表明这是提供 PrEP 的合适场所。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验